• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Cannabis

Here Are 3 Cannabis Stocks to Consider as They Face Significant Debt Issues

As most cannabis company stocks have risen in valuation over the past six months, it's worth looking at those that haven't.
By DEBRA BORCHARDT
Feb 05, 2021 | 02:00 PM EST
Stocks quotes in this article: TRSSF, ACB, CNTMF, KSHB, PLPRF

Long time cannabis industry investor Viridian Capital Advisors has recently issued a report that suggests looking at cannabis companies that may have a big debt bill coming due and insufficient cash to pay them. Viridian feels these companies have discounted valuations that present an investment opportunity.

While there has been a lot of capital flowing into the cannabis industry, most of it is going towards large companies. For example, last week North American cannabis operator TerrAscend Corp. (TRSSF) closed on a previously announced non-brokered private placement raising gross proceeds of C$224 million with 80% coming from four large U.S. institutional investors. There was also the Canadian cannabis company Aurora Cannabis (ACB) who closed on its previously announced public offering deal for total gross proceeds of $137 million. Still, these headlines generate interest in the smaller companies.

Jonathan DeCourcey, Director of Equity Research at Viridian wrote, "We expect companies with looming debts are more capable today to push off maturity dates (by incentivizing investors) or raise the requisite capital to pay off maturing debt than they had previously." He highlighted three companies that have big debt bills coming due and discounted valuations as opportunities even if the companies have to engage in dilutive financing deals. The companies were Cansortium (CNTMF) , KushCo Holdings (KSHB) , and Plus Products (PLPRF) .

Cansortium

Cansortium is a Florida-based company that also has business in Michigan and Pennsylvania. Viridian points out the company has $30 million in debt coming due in May and roughly $4 million in cash as of the third quarter in 2020. DeCourcey wrote, "If Cansortium issues $30 million in equity (or a convertible debt with equity conversion at the current price) to cover outstanding debts, the stock would still appear undervalued relative to the peer group." He went on to say that such an offering would value the company with an EBITDA of 9.4x, which is lower than the 13.5x multiple of other operators in the space with a market cap of less than $1 billion and 10.5x companies with a market cap of less than $500 million.

KushCo Holdings

Cannabis packaging company KushCo made a bold move last year as it decided to walk away from small companies who might not be able to pay their bills and focus on the big companies who could. Revenue fell in the short term and then the company was beset with pandemic challenges like delays at ports that held up inventory deliveries. Still, it looks like the company is turning a corner and business is getting stronger. Viridian noted that KushCo has $18 million in debt coming due in April and only $6 million in cash. KushCo addressed the issue and said it would be refinancing the debt.

DeCourcey believes that if KushCo can refinance its debt, it would be valued with an EBITDA of 8.7x, while similar operators are valued at 10.5x. He also thinks that if KushCo is able to uplist to the Nasdaq it would be a significant catalyst. "We note that KushCo could also find itself a takeout candidate for a SPAC with a looming liquidation deadline and interest in non-plant touching operators," he wrote.

Plus Products

Plus Products is known for its gummy products that are big sellers in the California market. The company recently got some star power with an endorsement from John Legend for the CBD products. Viridian points out that Plus has an $18 million convertible unsecured debt maturing at the end of February and $13 million in cash. "If Plus issues equity -- or convertible debt with equity conversion at the current price -- to cover the outstanding debt, the stock would still appear fairly valued given the company's positive fundamentals," DeCourcey wrote. He also thinks SPAC's may be interested in such a branded play as the company trades at a discount to its peers.

Most cannabis companies have been able to renegotiate the terms of their debts with lenders. It seems likely these companies will be successful with this as well. As most cannabis company stocks have risen in valuation over the past six months, it's worth looking at those that haven't. Each of the companies highlighted by Viridian are strong in their own right and led by very capable CEO's. There is certainly some merit to looking at these names as opportunities.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Debra Borchardt had no position in the securities mentioned.

TAGS: Debt Financing | Investing | Markets | Stocks | Trading | Cannabis

More from Cannabis

Want to Invest in Constellation Brands? Wait for a Discount

Stephen Guilfoyle
Apr 6, 2023 11:10 AM EDT

The quarter wasn't great, but the guidance was promising.

Doug Kass: Cannabis Stocks Are Still Not SAFE

Doug Kass
Dec 20, 2022 11:15 AM EST

Though it is tempting, there are a host of reasons why I'm not bottom fishing.

Cannabis ETFs Could Soon Turn a New Leaf

Mark Abssy
Dec 8, 2022 1:11 PM EST

With likely passage of new legislation, the pot industry might have a remedy for the nausea it gave investors.

3 Market Sectors Are Likely to Be Most Impacted by the Midterm Election

James "Rev Shark" DePorre
Nov 8, 2022 6:22 AM EST

The focus is on positioning for the election and CPI Thursday.

I'm Monitoring a Cannabis ETF That's Showing Signs of Bottoming

Bob Byrne
Nov 7, 2022 8:04 AM EST

It's a dicey play as the price action isn't defined as yet and the ETF still could break lower.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login